A biochemical compound developed as a radioactive tracer for cell proliferation shows increasing potential for use in cancer imaging, according to a recent paper published in the Pertanika Journal of Science & Technology. In the paper, an international team reviewed studies conducted over the past 30 years on a particular tracer, called "18F-FLT," and found that it has the potential to improve diagnostic imaging, and thus treatment, of some cancers.